Navigation Links
Lightlake Therapeutics Inc. to Apply Company's Patented Technology in the Development of Premenstrual Syndrome Overeating Treatment
Date:1/6/2012

nts who are obese or overweight as a result of Binge Eating Disorder in addition to those patients suffering from Bulimia Nervosa. Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of these purposes in the future.

Safe Harbor

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors. These and other factors may cause our actual results to differ materially from any forward- looking statement. We undertake no obligation to update any of the forward-looking statements after the date of this presentation to conform those statements to reflect the occurrence of unanticipated events, except as required by applicable law.

Investor Contact:
Mr. Kevin Fickle, President
NUWA Group LLC.
Tel: +1-925-330-8315
Email: '/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland
2. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
3. Orexigen Therapeutics to Present at the J.P. Morgan Healthcare Conference
4. Halo Therapeutics HT-100 Receives FDAs Orphan Designation for Duchenne Muscular Dystrophy
5. Echo Therapeutics Announces $3.6 Million Warrant Exercises
6. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
7. Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
8. AuraSense Therapeutics Secures Series B Equity Investment
9. PTC Therapeutics Antibacterial Program Receives $5 Million Award from the Wellcome Trust
10. Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics
11. Cerevast Therapeutics Receives CE Mark for Clotbust ER™ Ultrasound Stroke Treatment Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014  ConvaTec, a privately-held medical products and ... appointed Interim Chief Executive Officer of the company, effective ... Ken Berger .  "The Board of Directors of ConvaTec ... over the past three years," said Magnus Lundberg ... are confident that the company is well positioned for ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... the following open letter to shareholders from President ... Sc. Dear RXi Shareholders, ... inaccurate statements posted on certain social media sites ...
(Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE ... recombinant anthrax vaccine, has been filed and is now ... provided by the Department of Health and Human Services ... (BARDA). "We are extremely pleased to have ... Px563L.  This represents a significant milestone in our company,s ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
... September 30 Gamida Cell announced,today the publication of ... widely known as "StemEx", as a therapy for blood ... ex vivo expanded,umbilical cord blood cell graft for allogeneic ... Petropoulos, will be published in the,November 2009 issue of ...
... 30 GenVec, Inc. (Nasdaq: GNVC ) announced today ... and Research (SBIR) grant from the National Cancer Institute (NCI) ... research of a new approach to treating metastatic cancer. Under ... hypothesis that the delivery of a specific gene will stimulate ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3GenVec Receives National Cancer Institute Grant to Expand Cancer Program 2
(Date:12/24/2014)... Mike Billings , PT, MS, CEEAA, President ... PT, MBA, GCS, Director of Professional Development to discuss ... of the Improving Medicare Post-Acute Care Transformation Act ... the Infinicast, the two leaders discuss how the IMPACT ... to standardize post-acute assessment data for quality, payment, and ...
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... bisexual men who have abstained from sex for one year will ... new federal policy that would reverse a 31-year ban on donations ... and Drug Administration announced Tuesday its intention to release a new ... to blood donations from gay men. The FDA is changing ...
(Date:12/24/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Hepatitis C infection ... according to a new study. Treatment advances have made ... but many develop memory and thinking problems, mood swings and ... authors said. It,s believed that long-term infections with other ... may affect the brain. One of the prime suspects has ...
(Date:12/24/2014)... 2014 (HealthDay News) -- Adults who experienced childhood ... migraine headaches, suggests a study published online Dec. ... "Childhood maltreatment can have long-lasting effects, like associated ... study author Dawn Buse, director of behavioral medicine ... said in a journal news release. "When ...
(Date:12/24/2014)... Haelle HealthDay Reporter ... more likely to start smoking or drinking with each ... or conduct disorder, new research suggests. "Our ... risk of substance use as [these] children approach adolescence," ... Cincinnati Pediatric Research Group, which is part of Cincinnati ...
Breaking Medicine News(10 mins):Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3
... announced a computer network for the NHS, that would cost ... with a consortium of IT companies comprising of Atos Origin, ... and,will provide the NHS with national computer services for 11 ... health service payroll and nurse rosters. ,The consortium ...
... a rather unique show of exemplary medical prowess and ... John Hopkins //Comprehensive Transplant Center. This maiden feat was ... and 18 nurses and it took place over 10 ... the hospital has confirmed the good health of the ...
... research featured at ACP Foundation's Health Literacy Conference reports ... patient errors. //Most often, patients could not explain why ... much or how often should they take them. ... health literacy – says the research. ,Low ...
... increase the chances of heart attack, but cocaine lifts the ... study reported that ‘while sex causes very little increased risk ... 20-folds’. ,The review by University of Sydney and ... attacks, including sexual activity, cocaine use, pollution, heavy meals, and ...
... the risk of dementia according to recent research. // ... lower risk of dementia and Alzheimer’s disease. ,DHA or ... factor that is required for the proper functioning of the ... month’s issue of the Archives or Neurology. ,According to ...
... reported from strife-torn Afghanistan, have grown from a manageable 8 ... raised concern amongst health authorities as a significant cause of ... ,Anti-narcotics Minister Mohammad Zafar explained how the number of heroin ... to 14,000 in 2005. , ,'Forty to 50 percent ...
Cached Medicine News:Health News:Maiden Quintuple Kidney Transplant Sets a Record 2Health News:Low Health Literacy Is The Major Cause For Patient Errors 2
... This Sarmiento style Patella-Tendon-Bearing brace is designed ... the tibia and fibula. The tibial crest ... intra medullary nailing and removal of internal ... movement of joints above and below the ...
Designed as an excellent form of primary suspension...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... This lightweight orthosis is designed to ... joint while allowing unobstructed motion of ... more custom fit the splint may ... formed using a heat gun. One ...
Medicine Products: